文献速递心血管MR

伴与不伴右心室肥厚的肥厚型心肌病患者右心室整体应变研究

Right ventricular global strain in patients with hypertrophic cardiomyopathy with and without right ventricular hypertrophy.
PubMed 文献 · Eur J Radiol · 2023-10-11

回顾性纳入358例接受心脏磁共振检查并随访的肥厚型心肌病患者,用特征追踪技术测量右心室整体纵向应变和整体周向应变。中位随访25个月(范围3-54个月)内49例达到复合终点。伴右心室肥厚组右心室整体纵向应变与复合终点独立相关(HR 1.123),不伴右心室肥厚组右心室整体周向应变与复合终点独立相关(HR 1.174)。

要点

  • 右心室整体纵向应变是伴右心室肥厚肥厚型心肌病患者复合终点的独立预测因子(HR 1.123)。
  • 右心室整体周向应变是不伴右心室肥厚肥厚型心肌病患者复合终点的独立预测因子(HR 1.174)。
  • 右心室肥厚定义为舒张末期右心室最大壁厚≥5 mm。

核心结论

  • 右心室整体纵向应变和右心室整体周向应变分别是伴右心室肥厚和不伴右心室肥厚肥厚型心肌病患者的独立预测因子,可分别为两组提供额外的不良事件风险预测价值。

研究设计与样本

  • 回顾性研究,最终纳入358例接受心脏磁共振检查并完成随访的肥厚型心肌病患者,采用心脏磁共振特征追踪技术测量右心室整体纵向应变和整体周向应变,并评估观察者内和观察者间可重复性;终点为全因死亡、流产性心脏性猝死和心力衰竭再入院的复合终点。

诊断标准与关键数值

  • 右心室肥厚定义为舒张末期右心室最大壁厚≥5 mm;伴右心室肥厚组右心室整体纵向应变与复合终点独立相关(HR 1.123,95%CI 1.048-1.205,P=0.002);不伴右心室肥厚组右心室整体周向应变与复合终点独立相关(HR 1.174,95%CI 1.031-1.337,P=0.015)。

临床应用与阅片要点

  • 在肥厚型心肌病患者的磁共振报告与风险分层中,可根据有无右心室肥厚分别关注右心室整体纵向应变(伴右心室肥厚)或右心室整体周向应变(不伴右心室肥厚)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Regardless of whether there are morphological abnormalities of right ventricle in hypertrophic cardiomyopathy (HCM) patients, the exact contribution of right ventricular (RV) global strains remains unresolved. We aimed to study the prognostic value of RV global strains in HCM patients with and without RV hypertrophy (RVH).

METHOD: A total of 358 HCM patients who underwent the CMR examination and carried out the follow-up were finally included in this retrospective study. The endpoint was a composite of all-cause mortality, aborted SCD, and heart failure readmission. RV hypertrophy (RVH) was defined as maximal RVWT ≥ 5 mm at end-diastole. RV global strains (RV global longitudinal strain (GLS) and RV global circumferential strain (GCS) were measured in HCM patients by cardiac MRI feature tracking technique. The intraobserver and interobserver reproducibility were evaluated. Receiver-operating characteristic curves and Kaplan-Meier curves, cox proportional hazards regression, Likelihood ratio test and Integrated Discrimination Improvement (IDI) analysis were performed. P-value were corrected for multiple testing when using many covariables by a false discovery rate adjustment.

RESULTS: Over a median follow-up of 25 (range 3-54) months, 49 patients reached the composite endpoints. HCM patients were divided into the RVH group and non-RVH groups. In the multivariate cox proportional hazards regression, after adjusting multiple clinical and imaging variables, RV GLS and RV GCS were independently associated with the composite endpoints in the RVH group (HR: 1.123; 95 % CI: 1.048-1.205; P = 0.002) and non-RVH group (HR: 1.174; 95 % CI: 1.031-1.337; P = 0.015), respectively. And The IDI index of models improved when adding RV GLS (IDI = 0.030, p < 0.001) and RV GLS (IDI = 0.056, p = 0.020), respectively.

CONCLUSIONS: RV GLS and RV GCS are independent predictors of HCM with RVH and without RVH, respectively. RV GLS in the RVH group and RV GCS in the non-RVH group provide additional values for predicting the risk of adverse events.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Qian Y, Zhao X, Chen BH, et al. Right ventricular global strain in patients with hypertrophic cardiomyopathy with and without right ventricular hypertrophy. Eur J Radiol. 2023. PMID: 37871355. doi:10.1016/j.ejrad.2023.111148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。